MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-HR-05-0004979
Vamso Biotec Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹67.52 Cr
▲ 1% YoY
Net profit · FY 2025
₹2.08 Cr
Net margin 3.1%
EBITDA · FY 2025
₹3.71 Cr
EBITDA margin 5.5%
Authorised capital
₹6.75 Cr
Registered with MCA
Paid-up capital
₹25.87 Lakh
Issued & subscribed
Open charges
₹4.75 Cr
Satisfied ₹2.42 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
258
Provident fund records
About Vamso Biotec Private Limited
Data last updated:
Vamso Biotec Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Cril Fincap Private Limited. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 23 September 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL2005PTC141118. Its GSTIN is 05AACCV2319L1ZC (Uttarakhand). The company holds 18 GST registrations, of which 14 are active.
The company has an authorised share capital of ₹6.75 Cr and a paid-up capital of ₹25.87 Lakh. It is led by directors including Mukesh Agarwal (Managing Director) and Aakash Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at F 12 Adarshini Plaza91 Adhchini Sri Aurbindo Marg, New Delhi, Delhi, India – 110017.
As per the financials filed for FY 2025, the company reported a revenue of ₹67.52 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹2.08 Cr (net margin 3.1%) and EBITDA of ₹3.71 Cr (EBITDA margin 5.5%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 10% over five years.
The company has about 258 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.75 Cr and satisfied charges of ₹2.42 Cr on record. Court records list 143 cases involving the company, including 142 filed by the company and 1 filed against it; 12 cases are pending. The company has 8 deals on record (4 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹4.21 Cr; the latest was in January 2018. Its 6 peer companies in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Vivaldis Health and Foods Private Limited with revenue of ₹81.41 Cr.
Vamso Biotec Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-05-0004979). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vamso.in.
Company details
CIN U74899DL2005PTC141118
Registration Number 141118
Incorporation Date 23 September 2005
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Cril Fincap Private Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-HR-05-0004979
Recognitions & Rankings of Vamso Biotec
Contact details
Vamso Biotec Private Limited's registered office is in New Delhi, Delhi. Its website is vamso.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressF 12 Adarshini Plaza91 Adhchini Sri Aurbindo Marg, New Delhi, Delhi, India – 110017
- IndustryPharma, Animal Pharmaceuticals & Healthcare
To see the full contact details of Vamso Biotec Private Limited, buy the company report.
Comprehensive company report
Vamso Biotec Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Vamso Biotec is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vamso Biotec Private Limited, buy the company report.
Financials of Vamso Biotec Private Limited
FY 2024 filings availableVamso Biotec Private Limited reported revenue of ₹67.52 Cr (up 1% YoY) for FY 2025.
Revenue · FY 2025
₹67.52 Cr ▲ 1%
Net profit · FY 2025
₹2.08 Cr margin 3.1%
EBITDA · FY 2025
₹3.71 Cr margin 5.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 8%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 33%
3 years · compounded
▲ 11%
5 years · compounded
▲ 6%
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 1% growth in the latest year. EBITDA rose 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.71 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.08 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.5% | ||||
| Net Profit Margin | 3.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vamso Biotec Private Limited, buy the company report.
Board of directors of Vamso Biotec Private Limited
Vamso Biotec has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aakash Agarwal Also directs: Ikshan Enterprise Limited, Omkareshwari Exim Limited, Makams Industries Private Limited and 1 more | Director | 01 Jul 2016 | 10 Years 3 Months | Current |
| Ajay Agrawal Also directs: Dalmia Capital LLP | Director | 23 Sep 2005 | 21 Years 1 Months | Current |
| Mukesh Agarwal Also directs: Ikshan Enterprise Limited, Omkareshwari Exim Limited, Makams Industries Private Limited and 2 more | Managing Director | 23 Sep 2005 | 21 Years 1 Months | Current |
| Sanjay Kumar Agarwal | Director | 25 Nov 2008 | 17 Years 11 Months | Current |
Peer comparison
Vamso Biotec Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vivaldis Health and Foods Private Limited | ₹81.41 Cr (FY 2025) | 34.0% | Pune, Maharashtra, India | |||
| Amgis Lifescience Limited | ₹68.51 Cr (FY 2024) | 13.0% | Vapi, Gujarat, India | |||
| Pharmanza (India) Private Limited | ₹67.74 Cr (FY 2025) | 21.0% | Khambhat, Gujarat, India | |||
| Vamso Biotec Private Limitedthis company | ₹67.52 Cr (FY 2025) | ₹2.08 Cr | 3.1% | 1.0% | 258 | New Delhi, Delhi, India |
| Skyec Drugs and Pharmaceuticals Private Limited | ₹66.27 Cr (FY 2025) | 19.0% | Chennai, Tamil Nadu, India | |||
| Arbro Pharmaceuticals Private Limited | ₹64.16 Cr (FY 2025) | -9.0% | Delhi, India | |||
| Dips Bioscience Private Limited | ₹60.26 Cr (FY 2025) | 4.0% | Dombivali, Maharashtra, India |
To see the full peer comparison of Vamso Biotec Private Limited, buy the company report.
Auditor
Vamso Biotec Private Limited is audited by Ajeet Jalan & Co for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Ajeet Jalan & Co | FY 2024 | 012794N |
Shareholding
The shareholding of Vamso Biotec Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vamso Biotec Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.75 Cr
Satisfied charges
₹2.42 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Jul 2007 | 10062346 | Punjab National Bank | ₹4.75 Cr | Open | |
| 18 Jan 2016 | 10619209 | Punjab National Bank | ₹10 Lakh | Satisfied | |
| 28 Mar 2008 | 10102954 | Punjab National Bank | ₹12 Lakh | Satisfied | |
| 13 Jul 2007 | 10063745 | Punjab National Bank | ₹2 Cr | Satisfied | |
| 20 Sep 2006 | 10024285 | Bank of India | ₹20 Lakh | Satisfied |
To see the full charge records of Vamso Biotec Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Vamso Biotec Private Limited has 8 deals on record (4 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹4.21 Cr; the latest was in January 2018.
Total deals
8
Secondary share transfers
4
Funding rounds
3
Rights issue
1
Disclosed funding
₹4.21 Cr
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2018 | Rights issue | ₹1.05 Cr | Investors: Cril Fincap Private Limited |
| Jul 2016 | Secondary share transfer | Undisclosed | Buyer: Cril Fincap Private Limited Seller: Juno Credits & Investments Limited |
| Apr 2014 | Secondary share transfer | Undisclosed | Buyer: Cril Fincap Private Limited Seller: Omnipresent Credits Private Limited , Muskan Enterprises Private Limited |
| Apr 2014 | Secondary share transfer | Undisclosed | Buyer: Cril Fincap Private Limited Seller: Millenium Agro Systems Private Limited , Jenco Overseas Private Limited , Intelligent Share Brokers Private Limited |
| Sep 2011 | Secondary share transfer | Undisclosed | Buyer: Cril Fincap Private Limited Seller: Ambe Apparels Private Limited , Ars Marketing Private Limited |
To see the full deal history of Vamso Biotec Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Vamso Biotec Private Limited has 143 court cases on record: 142 filed by Vamso Biotec, 1 filed against it. 12 cases are pending and 131 are disposed.
Total cases
143
Filed by the company
142
Filed against the company
1
Pending
12
Disposed
131
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 143 | 1 | 12 |
Cases on record (5 of 143)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South, Delhi | Commercial suit | Filed by the company against M/S Alora Agritech Private Limited | Pending |
| District court, South, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Muzaffarnagar, Uttar Pradesh | Criminal case | Filed against the company by State of U.P. | Pending |
| District court, South, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Gurugram, Haryana | Cheque dishonour complaint | Filed by the company against M/S Nest Trade Links | Pending |
To see the full case history of Vamso Biotec Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vamso Biotec Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Vamso Biotec Private Limited has a workforce of 258 employees on its EPFO records as of Apr 05, 2025, across 1 active EPFO establishment.
Employee count
258
Active EPFO establishments
1
GST
Vamso Biotec has 18 GST registrations: 14 active and 4 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
18
Active
14
Cancelled / inactive
4
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AACCV2319L1ZC | Uttarakhand | Active | 01 Jul 2017 |
| 06AACCV2319L1ZA | Haryana | Active | 01 Jul 2017 |
| 08AACCV2319L1Z6 | Rajasthan | Active | 01 Jul 2017 |
| 09AACCV2319L1Z4 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vamso Biotec Private Limited, buy the company report.
Recent activity
Vamso Biotec Private Limited has 5 board changes on record since 2005: 4 appointments and 1 cessation. The latest: Aakash Agarwal was appointed as Director on 01 Jul 2016.
AGM
Vamso Biotec Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Vamso Biotec Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge registered on 18 Jan 2016 via Charge ID 10619209 with Punjab National Bank was fully satisfied on 06 Apr 2022.
Charges
A charge registered on 28 Mar 2008 via Charge ID 10102954 with Punjab National Bank was fully satisfied on 06 Apr 2022.
Appointed
Aakash Agarwal was appointed as Director.
Charges
A charge with Punjab National Bank amounted to Rs. 0.10 Cr with Charge ID 10619209 was registered on 18 Jan 2016.
Charges
A charge with Punjab National Bank of Rs. 4.75 Cr registered on 13 Jul 2007 with Charge ID 10062346 was modified on 15 Dec 2015.
Charges
A charge registered on 13 Jul 2007 via Charge ID 10063745 with Punjab National Bank was fully satisfied on 25 Jun 2014.
Charges
A charge with Punjab National Bank of Rs. 0.12 Cr registered on 28 Mar 2008 with Charge ID 10102954 was modified on 28 Mar 2011.
Ceased
Mukesh Agarwal ceased to be Director.
Appointed
Sanjay Kumar Agarwal was appointed as Director.
Charges
A charge with Punjab National Bank amounted to Rs. 0.12 Cr with Charge ID 10102954 was registered on 28 Mar 2008.
7 earlier events are in the company report.
Frequently asked questions
Vamso Biotec is an active private limited company based in New Delhi, Delhi, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 23 September 2005 (21+ years old) and is registered under CIN U74899DL2005PTC141118.
Vamso Biotec has 4 current directors:
- Mukesh Agarwal - Managing Director
- Aakash Agarwal - Director
- Ajay Agrawal - Director
- Sanjay Kumar Agarwal - Director
The latest financial statements of Vamso Biotec on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Vamso Biotec is 05AACCV2319L1ZC, registered in Uttarakhand. The company has 18 GST registrations in all, of which 14 are active and 4 are cancelled or inactive. Other active GSTINs include 06AACCV2319L1ZA (Haryana), 08AACCV2319L1Z6 (Rajasthan), 09AACCV2319L1Z4 (Uttar Pradesh).
The CIN (Corporate Identification Number) of Vamso Biotec is U74899DL2005PTC141118. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vamso Biotec has 143 court cases on record: 142 filed by the company and 1 filed against it. 12 are pending.
Vamso Biotec was incorporated on 23 September 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
Vamso Biotec has 8 deals on record (4 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹4.21 Cr; the latest was in January 2018.
The peers of Vamso Biotec by revenue are Vivaldis Health and Foods Private Limited, Amgis Lifescience Limited, Pharmanza (India) Private Limited, Skyec Drugs and Pharmaceuticals Private Limited, Arbro Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Aakash Agarwal was appointed as Director on 01 Jul 2016. Mukesh Agarwal ceased to be Director on 30 Nov 2009. Sanjay Kumar Agarwal was appointed as Director on 25 Nov 2008. Vamso Biotec has 5 board changes on record in total.
Yes, Vamso Biotec is registered as a medium enterprise under Udyam registration (number: UDYAM-HR-05-0004979).